ArticleOncology and therapyPublished
Cost-effectiveness of Nivolumab + Platinum Doublet Chemotherapy as Neoadjuvant Treatment for Resectable Non-Small Cell Lung Cancer in England
Regional connection
Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source
- Institution
- Bristol Myers Squibb
- County
- Mercer County
Publication record
- Type
- Article
- Venue
- Oncology and therapy
- Published
- Topic
- Public health
- Subject terms
- Cost-effectiveness; Neoadjuvant; Nivolumab; Non-metastatic Nsclc; Hta Submission
- PubMed ID
- 41241660
- PubMed Central ID
- PMC12992869
- Open access
- Yes, open
- Added to directory
- Source checked